ALL analyst estimates
Allstate (ALL) analyst ratings, the average price target and its range, and every firm's latest call.
ALL analyst ratings and price targets
| Date | Firm | Call | Target |
|---|---|---|---|
| Oct 12, 2026 | Wells Fargo | Wells Fargo Upgrades Allstate (ALL) to Equal Weight | $236.00 |
| Oct 7, 2026 | HSBC | Allstate upgraded to Buy from Hold at HSBC | $266.00 |
| Oct 7, 2026 | Barclays | Allstate price target lowered to $221 from $226 at Barclays | $221.00 |
| Oct 7, 2026 | Mizuho Securities | Allstate price target lowered to $295 from $300 at Mizuho | $295.00 |
| Oct 1, 2026 | Goldman Sachs | Allstate price target lowered to $250 from $280 at Goldman Sachs | $250.00 |
| Sep 18, 2026 | Mizuho Securities | Allstate price target raised to $300 from $297 at Mizuho | $300.00 |
| Sep 16, 2026 | Mizuho Securities | Allstate price target lowered to $297 from $300 at Mizuho | $297.00 |
| Aug 28, 2026 | Argus Research | Argus Downgrades Allstate (ALL) to Hold | $238.00 |
| Aug 11, 2026 | Raymond James | Allstate price target raised to $315 from $300 at Raymond James | $315.00 |
| Aug 11, 2026 | Morgan Stanley | Allstate price target raised to $265 from $240 at Morgan Stanley | $265.00 |
| Aug 10, 2026 | UBS | Allstate price target raised to $275 from $261 at UBS | $275.00 |
| Aug 7, 2026 | Wells Fargo | Allstate downgraded to Underweight from Equal Weight at Wells Fargo | $250.00 |
| Aug 7, 2026 | Goldman Sachs | Allstate price target raised to $280 from $250 at Goldman Sachs | $280.00 |
| Aug 6, 2026 | Barclays | Allstate price target raised to $226 from $213 at Barclays | $226.00 |
| Aug 6, 2026 | Roth Capital | Allstate price target raised to $300 from $275 at Roth Capital | $300.00 |
- 20 firms rate ALL: 7 buy, 10 hold, 3 sell.
- The average price target is $266.10 from 10 analysts, from $221.00 to $315.00.
Updated 2026-11-02 23:10 UTC